California Public Employees Retirement System’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-113,060
Closed -$3.16M 3020
2021
Q1
$3.16M Sell
113,060
-24,277
-18% -$679K ﹤0.01% 1717
2020
Q4
$3.89M Sell
137,337
-6,798
-5% -$193K ﹤0.01% 1569
2020
Q3
$3.62M Buy
144,135
+16,853
+13% +$424K ﹤0.01% 1461
2020
Q2
$3.11M Buy
127,282
+33,282
+35% +$813K ﹤0.01% 1521
2020
Q1
$1.39M Buy
94,000
+5,900
+7% +$87.3K ﹤0.01% 1804
2019
Q4
$1.43M Buy
88,100
+19,865
+29% +$322K ﹤0.01% 2192
2019
Q3
$887K Buy
68,235
+19,135
+39% +$249K ﹤0.01% 2334
2019
Q2
$637K Sell
49,100
-2,655
-5% -$34.4K ﹤0.01% 2421
2019
Q1
$816K Hold
51,755
﹤0.01% 2331
2018
Q4
$1.04M Buy
+51,755
New +$1.04M ﹤0.01% 2177
2016
Q1
Sell
-10,600
Closed -$362K 3608
2015
Q4
$362K Buy
+10,600
New +$362K ﹤0.01% 2947
2014
Q4
Sell
-15,769
Closed -$305K 3837
2014
Q3
$305K Buy
15,769
+5,698
+57% +$110K ﹤0.01% 3217
2014
Q2
$342K Buy
+10,071
New +$342K ﹤0.01% 3193